CYTOTECH ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About CYTOTECH ApS
CYTOTECH ApS (CVR number: 19898504) is a company from HELSINGØR. The company recorded a gross profit of 182.6 kDKK in 2023. The operating profit was -81 kDKK, while net earnings were -81.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -27.4 %, which can be considered poor and Return on Equity (ROE) was -41.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 68.6 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. CYTOTECH ApS's liquidity measured by quick ratio was 2.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 377.50 | 266.28 | 254.59 | 272.98 | 182.61 |
EBIT | 152.63 | -10.59 | -13.58 | 59.42 | -80.97 |
Net earnings | 149.31 | -10.78 | -14.51 | 50.68 | -81.31 |
Shareholders equity total | 212.17 | 201.39 | 186.88 | 237.56 | 156.25 |
Balance sheet total (assets) | 394.34 | 458.45 | 376.57 | 364.14 | 227.70 |
Net debt | - 238.57 | - 326.99 | - 314.66 | -96.97 | 61.50 |
Profitability | |||||
EBIT-% | |||||
ROA | 47.5 % | -2.5 % | -3.3 % | 16.0 % | -27.4 % |
ROE | 108.6 % | -5.2 % | -7.5 % | 23.9 % | -41.3 % |
ROI | 96.3 % | -5.1 % | -7.0 % | 21.9 % | -27.8 % |
Economic value added (EVA) | 151.11 | -9.26 | -7.27 | 57.98 | -82.10 |
Solvency | |||||
Equity ratio | 53.8 % | 43.9 % | 49.6 % | 65.2 % | 68.6 % |
Gearing | 49.8 % | 45.7 % | |||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 2.0 | 1.7 | 1.9 | 2.7 | 2.9 |
Current ratio | 2.0 | 1.7 | 1.9 | 2.7 | 2.9 |
Cash and cash equivalents | 238.57 | 326.99 | 314.66 | 215.20 | 9.94 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.